Hitt, Ricardo <br/><br/>
Phase II trial of dose-dense paclitaxel, cisplatin, 5-fluorouracil, and leucovorin with filgrastim support in patients with squamous cell carcinoma of the head and neck.  [electronic resource] 

 -  Cancer  Aug 2004 
 - 768-75 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/cncr.20439  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cisplatin--administration & dosage<br/>Drug Administration Schedule<br/>Female<br/>Filgrastim<br/>Fluorouracil--administration & dosage<br/>Granulocyte Colony-Stimulating Factor--administration & dosage<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Infusions, Intravenous<br/>Leucovorin--administration & dosage<br/>Male<br/>Middle Aged<br/>Neutropenia--chemically induced<br/>Paclitaxel--administration & dosage<br/>Recombinant Proteins<br/>Sepsis--chemically induced<br/>Survival Analysis<br/>Treatment Outcome